Cargando…
Challenges in the conduct of randomised controlled trials in cardiogenic shock complicating acute myocardial infarction
Cardiogenic shock (CS) following acute myocardial infarction (AMI) is a major challenge in cardiovascular care. Mortality remains high with 40%−50% after thirty days. Randomised controlled trials (RCTs) play a key role to generate evidence on optimal care in this field. However, the number of comple...
Autores principales: | Freund, Anne, Desch, Steffen, Thiele, Holger |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Science Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8915423/ https://www.ncbi.nlm.nih.gov/pubmed/35317398 http://dx.doi.org/10.11909/j.issn.1671-5411.2022.02.002 |
Ejemplares similares
-
Prognostic Impact of Active Mechanical Circulatory Support in Cardiogenic Shock Complicating Acute Myocardial Infarction, Results from the Culprit-Shock Trial
por: Feistritzer, Hans-Josef, et al.
Publicado: (2020) -
Contemporary Management of Cardiogenic Shock Complicating Acute Myocardial Infarction
por: De Luca, Leonardo, et al.
Publicado: (2023) -
Circulating Monocyte Chemoattractant Protein-1 in Patients with Cardiogenic Shock Complicating Acute Myocardial Infarction Treated with Mild Hypothermia: A Biomarker Substudy of SHOCK-COOL Trial
por: Cheng, Wenke, et al.
Publicado: (2022) -
Extracorporeal Membrane Oxygenation in Infarct-Related Cardiogenic Shock
por: Freund, Anne, et al.
Publicado: (2022) -
Circulating Galectin-3 in Patients with Cardiogenic Shock Complicating Acute Myocardial Infarction Treated with Mild Hypothermia: A Biomarker Sub-Study of the SHOCK-COOL Trial
por: Cheng, Wenke, et al.
Publicado: (2022)